Show simple item record

dc.contributor.authorHalamoda-Kenzaoui, B
dc.contributor.authorBox, H
dc.contributor.authorvan Elk, M
dc.contributor.authorGaitan, S
dc.contributor.authorGeertsma, RE
dc.date.accessioned2021-07-23T07:01:22Z
dc.date.available2021-07-23T07:01:22Z
dc.date.issued2020-12-24
dc.identifier.doi10.33218/001c.13521
dc.identifier.urihttp://hdl.handle.net/10029/625172
dc.language.isoenen_US
dc.titleLaunching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products.en_US
dc.typeArticleen_US
dc.identifier.journalPrec Nanomed 2020; 3(3):608-21en_US


This item appears in the following Collection(s)

Show simple item record